Trichostatin A

未知生产厂商

生成 AI 研报

技术标识符

化学式: C₁₇H₂₂N₂O₃
CAS 编号: 58880-19-6
UNII ID: 3X2S926L3Z

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CANCER TREATMENT
EP 3036007 B1申请人: VANDA PHARMACEUTICALS INC优先权: 2013
CN
EP
US
WO
13 件公开
COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS
EP 3820433 A1申请人: NUCHIDO LTD优先权: 2018
CN
EP
US
WO
5 件公开
Multiple myeloma treatment
US 11737993 B2申请人: VANDA PHARMACEUTICALS INC优先权: 2013
CN
US
5 件公开
Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
- US 8652502 B2
  申请人: FALOTICO ROBERT优先权: 2003
  CN
  EP
  US
  4 件公开
- US 2014004169 A1
  申请人: WYETH CORP优先权: 2013
  US
  2 件公开
Method of enhancing homologous recombination of somatic cells and method of constructing specific antibody
US 7776599 B2申请人: RIKEN优先权: 2002
US
4 件公开
HAT ACETYLATION PROMOTERS AND USES OF COMPOSITIONS THEREOF IN PROMOTING IMMUNOGENICITY
US 2010166781 A1申请人: TAPIMMUNE INC优先权: 2007
CN
US
3 件公开
COMBINATION OF ROSCOVITINE AND A HDCA INHIBITOR TO TREAT PROLIFERATIVE DISEASES
US 2009306098 A1申请人: CYCLACEL LTD优先权: 2005
CN
US
2 件公开
Method for screening anticancer agent
US 7407745 B1申请人: CHUGAI PHARMACEUTICAL CO LTD优先权: 1999
US
Use of an histone deacetylase inhibitor for the treatment of diseases associated with an hpv infection
US 2004132817 A1申请人: FINZER PATRICK优先权: 2001
US
Use of retinoids plus histone deacetylase inhibitors to inhibit the growth of solid tumors
US 2002183388 A1申请人: GUDAS LORRAINE J优先权: 2002
US

药物

Trichostatin A

专利

Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury